Articles related to PREGNANCY COMPLICATIONS

Pregnancy is well tolerated for many women with congenital heart disease, but outcomes vary substantially by underlying lesion and clinical characteristics. Current guidance emphasizes multidisciplinary counseling, structured risk assessment, and individualized management before conception.

A large ECHO Cohort analysis associated several pregnancy urinary chemical biomarkers with modest shifts in gestational age and fetal growth measures. The observational findings did not establish causality.

Pregnant participants who sat less and accumulated more light-intensity activity had roughly half the risk of a composite adverse pregnancy outcome in a 470-person prospective cohort study using thigh-worn accelerometers.

ACOG released its first maternal immunization schedule formally diverging from federal vaccine recommendations, following its February 2026 withdrawal from the CDC Advisory Committee on Immunization Practices over concerns about the committee’s scientific integrity.

The American Thyroid Association released updated evidence-based recommendations for thyroid disease in preconception, pregnancy, and postpartum, incorporating new trial data on LT4 treatment thresholds, TPOAb management, and ATD safety that diverge meaningfully from 2017 guidance.

Among 206,464 mother-child pairs, children of mothers with stably optimal glycemic management after a GDM diagnosis had obesity risk at age 10 nearly identical to children unexposed to GDM. Children of mothers with suboptimal trajectories had a 62% higher risk.